Saxenda (liraglutide) Saxenda (liraglutide) is FDA-approved for chronic weight management
As we age, when retatrutide accelerates weight loss in older patients, the double-whammy of age and fat loss can result in skin that is looser than in younger patients
A study published in 'Diabetes Care' in February 2023 indicated an elevated risk of all types of thyroid cancers in individuals using GLP-1 receptor agonists for one to three years
There was an increase in the 4enVPA metabolite of VPA
Jiang S, Yan C, Fang Q, Shao M, Zhang Y, Liu Y, et al
Third, if ACIP is going to demand for specific risk based criteria, or age based criteria that is not aligned with the FDA label, they may need to make it much more simpler and easier to interpret and administer in the community level, where patients are actually getting their immunizations, and that requires a whole set of changes in our health care, transfer of data and ability to be able to access that information